Articles From: EDAP Announces European Association of Urology Recommends HIFU for Treatment of Localized Prostate Cancer to Aegerion Pharmaceuticals Announces Webcast of Presentations at Upcoming Investor Conferences


LYON, France, April 24, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP) , the global leader in therapeutic ultrasound, announced that HIFU for the primary treatment and salvage therapy of localized prostate cancer are recommended by the European Urology Association in its 2014 Guidelines released in April at the EAU's Annual Congress held in Stockholm.
Sign-up for EDAP Announces European Association of Urology Recommends HIFU for Treatment of Localized Prostate Cancer investment picks
SUNNYVALE, Calif., April 24, 2014 (GLOBE NEWSWIRE) -- Alliance Fiber Optic Products, Inc. (Nasdaq:AFOP) , an innovative supplier of fiber optic components, subsystems and integrated modules for the fiber optic communication market, today reported its financial results for the first quarter ended March 31, 2014.
Sign-up for AFOP Reports Record Quarterly Sales and Profits in Q1 2014. Guidance for Year-Over-Year Increases of 31% in Q2 2014 investment picks
LIVERMORE, Calif., April 24, 2014 (GLOBE NEWSWIRE) -- Performant Financial Corporation (Nasdaq:PFMT) , a provider of technology-enabled recovery and related analytics services, today announced that the Company will release its first quarter 2014 results after the market close on Thursday, May 8, 2014.
Sign-up for Performant Financial Corporation Announces First Quarter 2014 Earnings Release Date and Teleconference investment picks
WILMINGTON, Del., April 24, 2014 (GLOBE NEWSWIRE) -- WSFS Financial Corporation (Nasdaq:WSFS) , the parent company of WSFS Bank, reported net income of $16.9 million, or $1.85 per diluted common share, for the first quarter of 2014 compared to net income of $9.0 million, or $1.02 per diluted common share, for the first quarter of 2013 and net income of $12.1 million, or $1.33 per diluted common share, for the fourth quarter of 2013.
Sign-up for WSFS Reports 1st Quarter 2014 EPS of $1.85, an 81% Increase Over 1st Quarter 2013; Aided by Recognition of Tax Benefit investment picks
NEW YORK, April 24, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against Apollo Education Group, Inc. ("Apollo" or the "Company") (Nasdaq:APOL) and certain of its officers.
Sign-up for Pomerantz Law Firm Announces the Filing of a Class Action Against Apollo Education Group, Inc. and Certain Officers -- APOL investment picks
MINNEAPOLIS, April 24, 2014 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (Nasdaq:SPSC) , a leading provider of on-demand supply chain management solutions, today announced financial results for the first quarter ended March 31, 2014.
Sign-up for SPS Commerce Reports First Quarter 2014 Financial Results investment picks
ATLANTA, April 24, 2014 (GLOBE NEWSWIRE) -- UPS (NYSE: UPS) today was notified by the International Brotherhood of Teamsters (IBT) that the Master Agreement between UPS and the IBT was approved for implementation on April 25 for all UPS employees covered by the Agreement.
Sign-up for UPS Contract with International Brotherhood of Teamsters Approved investment picks
HAMILTON, Bermuda, April 25, 2014 (GLOBE NEWSWIRE) -- Golar LNG Partners LP (Nasdaq:GMLP) announced today that its board of directors has declared a quarterly cash distribution with respect to the quarter ended March 31, 2014 of $0.5225 per unit.
Sign-up for Golar LNG Partners LP First Quarter 2014 Cash Distribution investment picks
BOSTON, April 29, 2014 (GLOBE NEWSWIRE) -- Winthrop Realty Trust (NYSE:FUR) ("Winthrop") announced today that its Board of Trustees has unanimously adopted a plan of liquidation, the implementation of which is subject to approval by the holders of a majority of Winthrop's common shares.
Sign-up for Winthrop Realty Trust to Seek Shareholder Approval to a Plan of Liquidation investment picks
NORTH HOLLYWOOD, Calif., May 8, 2014 (GLOBE NEWSWIRE) -- IPC The Hospitalist Company, Inc. (Nasdaq:IPCM) , a leading national hospitalist physician group practice company, announced today that it has acquired Total Inpatient Services, P.A. (TIPS), based in Sugar Land, Texas.
Sign-up for IPC The Hospitalist Company Acquires Texas Practice investment picks
DENVER, May 1, 2014 (GLOBE NEWSWIRE) -- Air Methods Corporation (Nasdaq:AIRM) will report financial results for the first quarter ended March 31, 2014 after the close of the market on Thursday, May 8, 2014.
Sign-up for Air Methods to Report First Quarter Financial Results After Market Close on Thursday, May 8, 2014 investment picks
DERIDDER, La., April 30, 2014 (GLOBE NEWSWIRE) -- AMERISAFE, Inc. (Nasdaq:AMSF) , a specialty provider of hazardous workers' compensation insurance, today announced results for the first quarter ended March 31, 2014.
Sign-up for AMERISAFE Announces 2014 First Quarter Results investment picks
NEW YORK, April 30, 2014 (GLOBE NEWSWIRE) -- The NASDAQ Stock Market ® (Nasdaq:NDAQ) announced that the trading halt status in Lihua International, Inc. (Nasdaq:LIWA) was changed to "additional information requested" from the company.
Sign-up for NASDAQ Halts Lihua International, Inc. investment picks
NEW YORK, May 1, 2014 (GLOBE NEWSWIRE) -- The NASDAQ Stock Market ® (Nasdaq:NDAQ) announced that trading was halted today in China Ceramics Co., Ltd.
Sign-up for NASDAQ Halts China Ceramics Co., Ltd. investment picks
CHATSWORTH, Calif., May 1, 2014 (GLOBE NEWSWIRE) -- Capstone Turbine Corporation (Nasdaq:CPST) (the "Company") today announced that it has entered into an underwriting agreement to sell 18,825,000 shares of its common stock at a price to the public of $1.70 per share for gross proceeds of approximately $32.0 million.
Sign-up for Capstone Turbine Announces Common Stock Offering investment picks
LYON, France, May 1, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP) , the global leader in therapeutic ultrasound, announced today details relating to its first quarter 2014 results announcement, which will take place on Thursday, May 15, 2014, before the opening of the market.
Sign-up for EDAP Schedules Webcast and Conference Call for First Quarter 2014 Results investment picks
RADNOR, Pa., May 1, 2014 (GLOBE NEWSWIRE) -- ICG Group, Inc. (Nasdaq:ICGE) ("ICG") today reported its results for the first quarter ended March 31, 2014.
Sign-up for ICG Announces First Quarter 2014 Financial Results investment picks
SAN DIEGO, May 1, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT) , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced that its Chief Financial Officer, Graham Cooper, will be presenting at the Deutsche Bank Securities Annual Healthcare Conference at the InterContinental Hotel in Boston.
Sign-up for Receptos to Present at Deutsche Bank Securities Annual Healthcare Conference investment picks
CHICAGO, May 1, 2014 (GLOBE NEWSWIRE) -- Durata Therapeutics, Inc. (Nasdaq:DRTX) has scheduled its quarterly conference call for Thursday, May 8 at 8:30 a.m. Eastern Time to discuss first quarter 2014 financial results.
Sign-up for Durata Therapeutics to Announce First Quarter 2014 Financial Results on May 8, 2014 investment picks
PHILADELPHIA , May 13, 2014 /PRNewswire/ -- Crown Cork & Seal USA , Inc., an affiliate of Crown Holdings, Inc. (NYSE: CCK) (Crown) ( www.crowncork.com ), has successfully reached a new, multi-year labor agreement with United Steelworkers (USW) Local Union 87-3.
Sign-up for New Labor Agreement With United Steelworkers Reached At Crown's Toledo Food Packaging Facility investment picks
- Dosing Initiated in Phase 1 Study to Evaluate the Safety, Tolerability and Antiviral Activity of ACH-3422, NS5B Uridine-Analog Nucleotide Prodrug - NEW HAVEN, Conn., April 30, 2014 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that is has begun dosing study participants with ACH-3422, Achillion's proprietary uridine-analog nucleotide inhibitor, in a Phase 1 clinical trial.
Sign-up for Achillion Advances ACH-3422, Uridine-Analog Nucleotide Inhibitor, Into Clinical Trial; Initiates Phase 2 Pilot Study With ACH-3102, NS5A Inhibitor, for HCV investment picks
http://media.marketwire.com/attachments/201305/152786_XUNLogoWhite25.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1118301&ProfileId=051205&sourceType=1 PORTLAND, OR --
Sign-up for Xun Energy Begins Completion of Rice #15 at Pennsylvania Oil Project investment picks
ATHENS, Greece , May 12, 2014 /PRNewswire/ -- Paragon Shipping Inc. (NASDAQ: PRGN) ("Paragon Shipping" or the "Company"), a global shipping transportation company specializing in drybulk cargoes, announced today that it will release its results for the first quarter ended March 31, 2014 , after the market closes in New York on Monday, May 19, 2014 .
Sign-up for Paragon Shipping Announces Date For The Release Of First Quarter 2014 Results, Conference Call And Webcast investment picks
SOUTH SAN FRANCISCO, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq:AKAO) , a clinical-stage biopharmaceutical company developing novel antibacterials to treat multi-drug resistant (MDR) gram-negative infections, today reported financial results for the quarter ended March 31, 2014.
Sign-up for Achaogen Announces First Quarter 2014 Results investment picks
Achieved Primary Endpoint of Complete Response (CR) in the Delayed Period (24 to 120 Hours) Following Initiation of Chemotherapy Achieved Key Secondary Endpoints of CR in the Acute and Overall Periods Achieved All Secondary Endpoints, Including No Significant Nausea Adverse Event Profile Consistent with Earlier Clinical Trials New Drug Application (NDA) Submission to U.S. FDA On Track for Mid-2014 WALTHAM, Mass., May 12, 2014 (GLOBE NEWSWIRE) -- TESARO, Inc. (Nasdaq:TSRO) , an oncology-focused biopharmaceutical company, today announced positive top-line results from the third and final Phase 3 trial of rolapitant, an investigational neurokinin-1 (NK-1) receptor antagonist in development for the prevention of chemotherapy-induced nausea and vomiting (CINV). The rolapitant arm in this trial, which enrolled patients receiving cisplatin-based, highly emetogenic chemotherapy (HEC), successfully achieved statistical significance over the standard
Sign-up for TESARO Announces Successful Achievement of Primary and All Secondary Endpoints in Third and Final Phase 3 Trial of Rolapitant investment picks
The world's smallest 5-mode LTE Advanced Carrier Aggregation modem, the Ericsson M7450, is fully tested and certified by China Mobile First devices integrating the Ericsson M7450 will be on the market in the second half of this year STOCKHOLM, Sweden, May 12, 2014 (GLOBE NEWSWIRE) -- Ericsson (NASDAQ: ERIC) today announced that the M7450 5-mode modem chipset, covering all five access technologies (TD-LTE, LTE FDD, WCDMA, TD-SCDMA and GSM), has been fully tested and certified for use in China Mobile's network.
Sign-up for China Mobile certifies Ericsson's LTE advanced modem investment picks
BRIDGEPORT, Pa., April 30, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Volt Solar Systems, Inc. (OTCBB:VOLT) announced today that it has received word from FINRA that its name change from First Power and Light, Inc. will be effective at the open of the market on May 1, 2014.
Sign-up for VOLT Name Change Effective and New Sales and Construction Office Opened in Massachusetts investment picks
NOVATO, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq:RARE) , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced the presentation of detailed results from a 48-week Phase 2 clinical study of sialic acid extended-release (SA-ER, UX001) tablets in 47 patients with hereditary inclusion body myopathy (HIBM; also known by its new name as GNE myopathy), a rare, progressive muscle-wasting disease.
Sign-up for Ultragenyx Announces Positive Data From Phase 2 Study of Sialic Acid Extended-Release at Emerging Sciences Session of American Academy of Neurology Annual Meeting investment picks
CAMBRIDGE, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) , a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced today that the company will participate in Deutsche Bank 39 th Annual Health Care Conference in Boston.
Sign-up for Aegerion Pharmaceuticals Announces Webcast of Presentations at Upcoming Investor Conferences investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: EDAP Announces European Association of Urology Recommends HIFU for Treatment of Localized Prostate Cancer to Aegerion Pharmaceuticals Announces Webcast of Presentations at Upcoming Investor Conferences
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry